Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-11-04

FDA Approved: ALLERGY RELIEF — Supplemental Application (Publix Super Markets Inc)

View source ↗

Summary

FDA approved a supplemental application for Allergy Relief (fexofenadine hydrochloride) from Publix Super Markets Inc under ANDA 212971.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY RELIEF (cetirizine hydrochloride)

Snippet

SUPPL AP for ALLERGY RELIEF (FEXOFENADINE HYDROCHLORIDE)